Researchers have found that an existing diabetes drug can be used to halt progression of another disease that is a leading cause of liver transplants. A three-year clinical trial led by University of ...

MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today that Takeda Pharmaceutical Co.'s $2.37 billion settlement over their diabetes ...

Nevada case involves allegations that women developed cancer as a result of Actos medication. National network of attorneys is offering no-cost consultations to consumers seeking compensation over ...

In a groundbreaking class action, Wisner Baum LLP is invoking the civil RICO statute to hold Takeda and Eli Lilly accountable for allegedly concealing the cancer risks of diabetes drug Actos. The case ...

This case concerned the diabetes medication ACTOS and whether its manufacturer, Takeda, violated antitrust laws by misdescribing its patent rights to the Food and Drug Administration, which in turn ...

Share on Pinterest New research indicates a drug used to treat type 2 diabetes may help lower the risk of dementia. Fertnig/Getty Images Researchers are saying the drug pioglitazone may help reduce ...

CHICAGO (AP) -- The widely used diabetes pill Actos appears to lower a patient's chances of death, heart attack or stroke, unlike its beleaguered chief rival Avandia, a new analysis shows. However, it ...

An older diabetes drug may help lower the risk for dementia in older people with new-onset type 2 diabetes, a Korean study suggested. Among more than 91,000 newly-diagnosed diabetes patients ages 50 ...

NEW YORK (Reuters) - The high-profile experimental once-weekly injectable diabetes drug from Amylin Pharmaceuticals Inc and Eli Lilly and Co proved superior to the widely used medicines Actos and ...

CHICAGO - The widely used diabetes pill Actos appears to lower a patient's chances of death, heart attack or stroke, unlike its beleaguered chief rival Avandia, a new analysis shows. However, it also ...